Delivery Order SPE2DB20D3103-SPE2DB25FL4P0
Award Date
10/22/24
Potential Completion Date
10/23/24
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,854.65 firm fixed-price delivery order is for the supply of Granisetron HCL 1 mg tablets to support military healthcare programs. The contract has a completion date of May 20, 2024 and was awarded on May 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of granisetron HCL 1 mg tablets. The $3,064.09 firm fixed price delivery order is not associated with a set-aside program and has an ultimate completion date of June 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,674.06 firm fixed-price delivery order is for the supply of 4560863588 - Granisetron HCL 1 mg Tablet UD 20s, with a completion date of May 9, 2023. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of Granisetron HCL 1 mg Tablet UD 20s, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $18,162.43 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of May 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $24,164.42, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of Granisetron Hydrochloride 1 mg Tablets, a prescription medication, to support military healthcare programs. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,409.90 firm fixed-price delivery order is for the supply of 4566796601 - GRANISETRON HCL 1 MG TABLET UD 20S, with a completion date of December 27, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award is for the delivery of Granisetron HCL 1 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $16,393.09. The contract has an ultimate completion date of November 14, 2024 and is a Firm Fixed Price contract type. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract. The $20,983.81 firm-fixed-price contract is for the supply of Granisetron Hydrochloride 1 mg Tablets, a medication used to prevent nausea and vomiting associated with chemotherapy. The award has a completion date of September 9, 2024 and does not utilize a socioeconomic set-aside...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Granisetron HCL 1 mg Tablets in 20-count units, with a ceiling value of $50,326.20 and a period of performance through January 16, 2025. There was no set-aside designation for this open-competition contract award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Granisetron HCL 1 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The firm-fixed-price delivery order, valued at $5,806.85, has an ultimate completion date of December 6, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...